40 likes | 166 Vues
This study analyzes data from the National Ambulatory Medical Care Survey, focusing on drug mentions during physician visits by patients aged 25 and older. It reveals a significant rise in drug mentions per 100 population from 1995 to 2004, with a notable acceleration in 2003-2004. Specific drug classes, including cardiovascular-renal, pain-relief, and central-nervous system agents, contributed to this increase. Potential hypotheses for these trends include the aging population, increasing prevalence of severe diseases, and heightened awareness of health and nutrition.
E N D
Anthony Don(don@cs.umd.edu) Data from the National Ambulatory Medical Care Survey on drug mentions at physician office visits by patients aged 25 years and over. Author: NCHS. http://www.cdc.gov/nchs/health_data_for_all_ages.htm
Drug mentions Rates of drug mentions per 100 population Overall increase of the number of drug mentions per 100 population over the 1995-2004 period. The increase accelerates in 2003-2004. The contribution of specific drug classes to the overall increase is visible, especially : cardiovascular-renal drugs, pain-relief drugs,central-nervous system and metabolic/nutrient agents.
Aging population ? This suggests several hypothesis to explain these trends : - increase of severe diseases due to an aging population, - harder stress conditions - more concern about nutrition and health. Distribution of age classes across the population
Distribution of mentions Distribution of drug mentions across age classes People from the older age classes use a larger part of the overall mentions.